148 related articles for article (PubMed ID: 7362643)
1. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
Glazer RI; Peale AL
Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
[No Abstract] [Full Text] [Related]
2. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
3. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
Glazer RI; Hartman KD; Cohen OJ
Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
[No Abstract] [Full Text] [Related]
4. Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
Kann HE; Kohn KW
Mol Pharmacol; 1972 Sep; 8(5):551-60. PubMed ID: 4117298
[No Abstract] [Full Text] [Related]
5. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.
Ritch PS; Glazer RI
Biochem Pharmacol; 1982 Jan; 31(2):259-61. PubMed ID: 7059368
[No Abstract] [Full Text] [Related]
6. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
Li ZR; Feng JB; Liang F; Zeng SX; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
[No Abstract] [Full Text] [Related]
7. Reversal of the cytotoxicity of 3'-amino-3'-deoxythymidine by pyrimidine deoxyribonucleosides.
Fischer PH; Lin TS; Prusoff WH
Biochem Pharmacol; 1979 Apr; 28(7):991-4. PubMed ID: 444292
[No Abstract] [Full Text] [Related]
8. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
Wang JJ; Chervinsky DS; Rosen JM
Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
[No Abstract] [Full Text] [Related]
9. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
Ritch PS; Glazer RI; Cunningham RE; Shackney SE
Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of methylation of nuclear ribonucleic acid in L1210 cells by tubercidin, 8-azaadenosine and formycin.
Stern HJ; Glazer RI
Biochem Pharmacol; 1980 Jun; 29(11):1459-64. PubMed ID: 7396981
[No Abstract] [Full Text] [Related]
11. New antitumor antibiotic, FR-900405. III. Mechanism of action of FR-900405.
Kiyoto S; Shibata T; Kawai Y; Hori Y; Nakayama O; Terano H; Kohsaka M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1985 Jul; 38(7):955-6. PubMed ID: 4030506
[No Abstract] [Full Text] [Related]
12. The effect of 5-fluorouracil on the synthesis of nuclear RNA in L1210 cells in vitro.
Glazer RI; Peale AL
Mol Pharmacol; 1979 Jul; 16(1):270-7. PubMed ID: 481421
[No Abstract] [Full Text] [Related]
13. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
Meriwether WD; Bachur NR
Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
[No Abstract] [Full Text] [Related]
14. In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells.
Chang JC; Hall TC
Oncology; 1973; 28(3):232-7. PubMed ID: 4767109
[No Abstract] [Full Text] [Related]
15. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
16. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
Kessel D
Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
[No Abstract] [Full Text] [Related]
17. The effect of 5-fluorouracil on the synthesis and methylation of low molecular weight nuclear RNA in L1210 cells.
Glazer RI; Hartman KD
Mol Pharmacol; 1980 Mar; 17(2):245-9. PubMed ID: 7393205
[No Abstract] [Full Text] [Related]
18. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
Allen LM; Creaven PJ
Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
[No Abstract] [Full Text] [Related]
19. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Stockwin LH; Yu SX; Stotler H; Hollingshead MG; Newton DL
BMC Cancer; 2009 Feb; 9():63. PubMed ID: 19232100
[TBL] [Abstract][Full Text] [Related]
20. Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
Martinez AP; Lee WW; Henry DW
J Med Chem; 1977 Mar; 20(3):341-4. PubMed ID: 845866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
